OmniAb (OABI) Total Debt Growth (1y) (2022 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 5.94% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 103.99% |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn | 183.85% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 183.85% |
| Dec 31, 2025 | 96.61% |
| Sep 30, 2025 | 40.98% |
| Jun 30, 2025 | 242.38% |
| Mar 31, 2025 | -60.38% |
| Dec 31, 2024 | -59.25% |
| Sep 30, 2024 | -70.91% |
| Jun 30, 2024 | -88.33% |
| Mar 31, 2024 | -63.94% |
| Dec 31, 2023 | -67.60% |
| Sep 30, 2023 | 1,885.41% |
| Jun 30, 2023 | 4,772.89% |
| Mar 31, 2023 | 5,696.25% |
| Dec 31, 2022 | 58.47% |
| Jun 30, 2022 | 1,153,220.00% |